Literature DB >> 23277129

Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2.

Claudio Toma1, Amaia Hervás, Bàrbara Torrico, Noemí Balmaña, Marta Salgado, Marta Maristany, Elisabet Vilella, Rafael Martínez-Leal, Ma Inmaculada Planelles, Ivon Cuscó, Miguel del Campo, Luis A Pérez-Jurado, Rafaela Caballero-Andaluz, Yolanda de Diego-Otero, Lucía Pérez-Costillas, Josep A Ramos-Quiroga, Marta Ribasés, Mònica Bayés, Bru Cormand.   

Abstract

Impairment of language abilities is a common feature in autistic individuals. Heterozygous mutations in the Forkhead Box P2 (FOXP2) gene lead to a severe spoken language disorder. Recently, several studies have pinpointed the involvement of common variants of the Contactin-Associated Protein-Like 2 (CNTNAP2) gene, whose transcription is regulated by the product of FOXP2, in several disorders characterized by language impairments such as autism, specific language impairment (SLI), and selective mutism (SM). In the present study, common variants of the FOXP2 and the CNTNAP2 genes were analyzed through a case-control association study in 322 Spanish autistic patients and 524 controls. The results of this study suggest that common variants of FOXP2 are unlikely to contribute to autism susceptibility, in agreement with previous findings. Furthermore, we failed to replicate in our sample a previous association finding of two single nucleotide polymorphisms (rs2710102 and rs7794745) in the CNTNAP2 gene with autism. No evidence for the association of these genes with language traits was observed in our analysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277129     DOI: 10.1097/YPG.0b013e32835d6fc6

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  26 in total

1.  Modification of spectral features by nonhuman primates.

Authors:  Daniel J Weiss; Cara F Hotchkin; Susan E Parks
Journal:  Behav Brain Sci       Date:  2014-12       Impact factor: 12.579

Review 2.  Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02-03

Review 3.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

4.  Recent Advances in the Genetics of Vocal Learning.

Authors:  Michael C Condro; Stephanie A White
Journal:  Comp Cogn Behav Rev       Date:  2014

Review 5.  Intragenic CNTNAP2 Deletions: A Bridge Too Far?

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-02-10

Review 6.  Insights into the genetic foundations of human communication.

Authors:  Sarah A Graham; Pelagia Deriziotis; Simon E Fisher
Journal:  Neuropsychol Rev       Date:  2015-01-18       Impact factor: 7.444

Review 7.  Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration.

Authors:  Toshifumi Fukuda; Shigeru Yanagi
Journal:  Cell Mol Life Sci       Date:  2017-05-17       Impact factor: 9.261

8.  CNTNAP2 gene in high functioning autism: no association according to family and meta-analysis approaches.

Authors:  Anna Maria Werling; Elise Bobrowski; Regina Taurines; Ronnie Gundelfinger; Marcel Romanos; Edna Grünblatt; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2015-11-11       Impact factor: 3.575

9.  CNTNAP2 gene polymorphisms in autism spectrum disorder and language impairment among Bangladeshi children: a case-control study combined with a meta-analysis.

Authors:  Mohammad Sarowar Uddin; Atkia Azima; Md Abdul Aziz; Tutun Das Aka; Sarah Jafrin; Md Shalahuddin Millat; Shafayet Ahmed Siddiqui; Md Giash Uddin; Md Saddam Hussain; Mohammad Safiqul Islam
Journal:  Hum Cell       Date:  2021-05-05       Impact factor: 4.174

Review 10.  FOXP transcription factors in vertebrate brain development, function, and disorders.

Authors:  Marissa Co; Ashley G Anderson; Genevieve Konopka
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2020-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.